Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients
Year: 1996
Type: article
Study design: Observational Study
Source: Nature Medicine
DOI: 10.1038/nm0796-811
Institution: Haukeland University Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1987783969
